middle.news
AdAlta Secures A$0.5M at Premium to Fuel CAR-T Therapy Ambitions
9:07am on Monday 13th of October, 2025 AEDT
•
Biotechnology
Read Story
AdAlta Secures A$0.5M at Premium to Fuel CAR-T Therapy Ambitions
9:07am on Monday 13th of October, 2025 AEDT
Key Points
A$0.5 million raised via non-brokered private placement at 20% premium
Placement led by Hong Kong-based sophisticated investor David Pevcic
Funds to advance licensing and collaboration agreements for CAR-T therapies
Part of placement subject to shareholder approval with shares and options issued
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Adalta (ASX:1AD)
OPEN ARTICLE